By Joseph Bikowski, MD, FAAD
Successful practices use benchmarking to compare their performance to others, assess their own performance over time, and plan for the long term.
By Robert Thorne, CPA
Don’t build a website “because everyone else has one.” Build a tool that sets your practice apart.
By Susan M. Hutson with Vikas Vij
Practical considerations for integrating lasers and energy based devices in a dermatology practice.
By Vic Narurkar, MD and Ava Shamban, MD
CMS released data for EHR use in 2011, but next year’s data will likely determine the role EHRs will play in the future of dermatology.
By Mark Kaufmann, MD
Starting out small and adding new techniques one at a time is critical in the use of fillers in practice.
By Joel Schlessinger, MD
Other findings include three-year safety data for a novel IL agent and the important role dermatologists could play in diagnosis of psoriatic arthritis.
Potentially expanding the class of interleukin therapy, two investigational agents show possible long-term effects in management of moderate-to-severe psoriasis.
Evidence increasingly suggests that dermatologists need to watch for allergens in AD—from the interaction between environmental allergens and eczema to corticosteroid allergy.
By Leon H. Kircik, MD and James Q. Del Rosso, DO
Offering patients education, resources, support, and an active role in treatment selection are all ways to empower them and help ensure a better experience in the long-term.
By April Armstrong, MD, MPH
From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.
By Madelaine Haddican, MD and Gary Goldenberg, MD
Part III in a series highlights how to attract, hire, and maintain a physician assistant in your dermatology practice
By Matthew Zirwas, MD and Vicki Roberts, PA-C
Innovations in technology are paving the way for products that address skin care and sun protection needs.
By Joshua Zeichner, MD
Researched assessed inflammatory markers in the exhaled breath condensate (EBC) of children with AD (n=33) or healthy controls (n=23). EBC was collected using a condenser device and assessed for pH and concentrations of leukotr... more >
Sunscreen manufacturers have won a small victory from the Food and Drug Administration (FDA), which has extended the deadline for compliance with new labeling back to December 2013 for some companies. The industry pushed back ... more >
Fibrocell Science, Inc. has proposed its Phase II clinical study protocol to evaluate the safety and efficacy of Fibrocell’s lead therapy, azficel-T, to the US Food and Drug Administration (FDA). azficel-T was studied for its ... more >
Healthcare spending in the United States is expected to grow at a historically low rate of 7.5 percent next year, according to a recently published medical cost trend by PricewaterhouseCooper’s (PwC’s) Health Research Insti... more >
Advertisement
Potentially expanding the class of interleukin therapy, two investigational agents show possible long-term effects in management of moderate-to-severe psoriasis.
From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.
By Madelaine Haddican, MD and Gary Goldenberg, MD
Evidence increasingly suggests that dermatologists need to watch for allergens in AD—from the interaction between environmental allergens and eczema to corticosteroid allergy.
By Leon H. Kircik, MD and James Q. Del Rosso, DO
Successful practices use benchmarking to compare their performance to others, assess their own performance over time, and plan for the long term.
By Robert Thorne, CPA
Part III in a series highlights how to attract, hire, and maintain a physician assistant in your dermatology practice
By Matthew Zirwas, MD and Vicki Roberts, PA-C